Seth M. Steinberg

National Cancer Institute

Papers

1

Total Citations

8

H-Index

1

About

Seth M. Steinberg is a prominent researcher in cancer biology and precision oncology, with a focus on esophageal cancers and therapeutic response mechanisms. His major contributions center on developing novel assessment methods to personalize treatment, particularly through metabolomic and BH3 profiling. His landmark 2018 study introduced these techniques as innovative tools for evaluating precision therapy in esophageal cancers, addressing a critical need in a disease that accounts for nearly 16,000 deaths annually. This work has garnered significant attention, accumulating 8 citations and establishing a foundation for tailoring neoadjuvant chemoradiotherapy (nCRT) strategies. Steinberg’s research directly targets the challenge of identifying patients who achieve a pathological complete response, aiming to improve outcomes and reduce unnecessary interventions. His achievements include advancing the integration of metabolic and apoptotic profiling into clinical decision-making, offering a pathway to more effective, individualized cancer care. Through these efforts, Steinberg has made a lasting impact on the field, providing tools that could transform treatment paradigms for esophageal cancer patients and inspire further investigation into precision oncology approaches.

Research Focus

Key Achievements

1
H-Index
1
Papers
8
Total Citations
8
Avg Citations/Paper
🏆 Most Cited Paper
Metabolomic and BH3 profiling of esophageal cancers: novel assessment methods for precision therapy
8 citations · 2018
📈 Most Prolific Year: 2018 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: National Cancer Institute

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago